ITP1: Interventions Testing Program: Effects of various treatments on lifespan and related phenotypes in genetically heterogeneous mice (UM-HET3) (2017)

Miller RA, Strong JR, Harrison DE

     
The Interventions Testing Program (ITP, National Institute on Aging) is a multi-institutional study investigating treatments with the potential to extend lifespan and delay disease and dysfunction in heterogeneous populations of UM-HET3 mice. Such treatments include pharmaceuticals, nutraceuticals, foods, diets, dietary supplements, plant extracts, hormones, peptides, amino acids, chelators, redox agents, and other agents or mixtures of agents. The three ITP test sites (with abbreviations as used in these data) are:
  • The Jackson Laboratory (TJL)
  • University of Michigan at Ann Arbor (UM)
  • University of Texas Health Science Center (UT)

ITP1 downloads
See below for available data set downloads.
Participants Richard A Miller       University of Michigan Ann Arbor, MI
John R Strong       University of Texas Health Science Center San Antonio, TX
David E Harrison       The Jackson Laboratory Bar Harbor, ME
ContactRichard A Miller     millerr@umich.edu     Lab web site
AffiliationNational Institute on Aging Interventions Testing Program (ITP)
AcknowledgementsFunding provided by NIH AG022303, AG022307, AG022308
Project type Phenotype archive study
MPD identifiersITP1     MPD:508
Data changelog No updates/corrections.       Initial release date: 06/2017.
Formatted citation
Click above to copy-paste the entire citation for this MPD web page.
View protocol document    


Studied
compound     		Code Dose in food Age at initiation Effect on lifespan* Other phenotypes Cohort Ref#
acarbose ACA 1000 ppm 16 mo View survival analysis
males     p < 0.001		 C2012 [10]
fish oil FO 15,000 and 50,000 ppm 9 mo View survival analysis body weight C2010 [10]
metformin Met 1000 ppm 9 mo View survival analysis C2011 [10]
metformin and rapamycin MetRapa 1000 ppm Met
14 ppm Rapa		 9 mo View survival analysis
females  p < 0.001
males     p < 0.001		 C2011 [10]
nordihydroguaiaretic acid NDGA 800, 2500, and 5000 ppm 6 mo View survival analysis
males     p = 0.003		 grip strength and duration; rotarod C2010 [10]
Protandim Prot 600 ppm then 1200 ppm 10 mo,
17 mo		 View survival analysis
males     p = 0.009		 body weight C2011 [10]
ursodeoxycholic acid UDCA 5000 ppm 5 mo View survival analysis body weight C2011 [10]
17-a-estradiol 17aE2 4.8 and 14.4 ppm 10 mo View survival analysis
males     p < 0.001		 body weight; uterus weight ovariectomy study C2011 [10]

* Log-rank test p-value on treated vs. control, shown when p ≤ 0.05 for each sex separately, best from any dose.








References   (chronological)

1.   Miller RA, Harrison DE, Astle CM, Floyd RA, Flurkey K, Hensley KL, Javors MA, Leeuwenburgh C, Nelson JF, Ongini E, Nadon NL, Warner HR, Strong R. An Aging Interventions Testing Program: study design and interim report. Aging Cell. 2007 Aug;6(4):565-75. Epub 2007 Jun 18.   PubMed 17578509  

2.   Strong R, Miller RA, Astle CM, Floyd RA, Flurkey K, Hensley KL, Javors MA, Leeuwenburgh C, Nelson JF, Ongini E, Nadon NL, Warner HR, Harrison DE. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell. 2008 Oct;7(5):641-50. doi: 10.1111/j.1474-9726.2008.00414.x.   PubMed 18631321     FullText

3.   Nadon NL, Strong R, Miller RA, Nelson J, Javors M, Sharp ZD, Peralba JM, Harrison DE. Design of aging intervention studies: the NIA interventions testing program. Age (Dordr). 2008 Dec;30(4):187-99. doi: 10.1007/s11357-008-9048-Epub 2008 Apr 18.   PubMed 19424842     FullText

4.   Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009 Jul 16;460(7253):392-5. doi: 10.1038/nature0822Epub 2009 Jul 8.   PubMed 19587680     FullText

5.   Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong R. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011 Feb;66(2):191-20doi: 10.1093/gerona/glq178. Epub 2010 Oct 25.   PubMed 20974732     FullText

6.   Strong R, Miller RA, Astle CM, Baur JA, de Cabo R, Fernandez E, Guo W, Javors M, Kirkland JL, Nelson JF, Sinclair DA, Teter B, Williams D, Zaveri N, Nadon NL, Harrison DE. Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):6-16. doi: 10.1093/gerona/gls070. Epub 2012 Mar 26.   PubMed 22451473     FullText

7.   Wilkinson JE, Burmeister L, Brooks SV, Chan CC, Friedline S, Harrison DE, Hejtmancik JF, Nadon N, Strong R, Wood LK, Woodward MA, Miller RA. Rapamycin slows aging in mice. Aging Cell. 2012 Aug;11(4):675-82. doi: 10.1111/j.1474-9726.2012.00832.x. Epub 2012 Jun 4.   PubMed 22587563     FullText

8.   Harrison DE, Strong R, Allison DB, Ames BN, Astle CM, Atamna H, Fernandez E, Flurkey K, Javors MA, Nadon NL, Nelson JF, Pletcher S, Simpkins JW, Smith D, Wilkinson JE, Miller RA. Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell. 2014 Apr;13(2):273-82. doi: 10.1111/acel.12170. Epub 2013 Nov 19.   PubMed 24245565     FullText

9.   Miller RA, Harrison DE, Astle CM, Fernandez E, Flurkey K, Han M, Javors MA, Li X, Nadon NL, Nelson JF, Pletcher S, Salmon AB, Sharp ZD, Van Roekel S, Winkleman L, Strong R. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell. 2014 Jun;13(3):468-77. doi: 10.1111/acel.12194. Epub 2014 Feb 9.   PubMed 24341993     FullText

10.   Strong R, Miller RA, Antebi A, Astle CM, Bogue M, Denzel MS, Fernandez E, Flurkey K, Hamilton KL, Lamming DW, Javors MA, de Magalhães JP(9), Martinez PA, McCord JM(10), Miller BF, Müller M(11), Nelson JF(12), et al. Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. Aging Cell. 2016 Oct;15(5):872-84. doi: 10.1111/acel.12496. Epub 2016 Jun 16.   PubMed 27312235